Successful Use of Recombinant Activated Factor VII to Reverse Ticagrelor-Induced Bleeding Risk: A Case Report

Management of ticagrelor-associated bleeding is challenging, especially in neurosurgery. Platelet transfusion is inefficient and no antidote is currently available. We report here the first case of recombinant activated factor VII (rFVIIa) use to bypass ticagrelor-induced platelet inhibition. A woma...

Descripción completa

Detalles Bibliográficos
Autores principales: Godier, Anne, Dupont, Mélanie, Desilles, Jean-Philippe, Le Guerinel, Caroline, Taylor, Guillaume, Perrin, Mathilde, Martin, Anne-Céline, Gaussem, Pascale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524896/
https://www.ncbi.nlm.nih.gov/pubmed/31249959
http://dx.doi.org/10.1055/s-0038-1672211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524896/
https://www.ncbi.nlm.nih.gov/pubmed/31249959
http://dx.doi.org/10.1055/s-0038-1672211

Ejemplares similares